ClinicalTrials.Veeva

Menu

Xenogenic Collagen Matrix for the Treatment of Multiple Gingival Recessions

U

University of Turin

Status

Enrolling

Conditions

Gingival Recession, Generalized

Treatments

Procedure: Treatment of MAGRs with CTG
Device: Use of XCM for the treatment of MAGRs with mCAF technique

Study type

Interventional

Funder types

Other

Identifiers

NCT05693753
XCMTurin

Details and patient eligibility

About

The primary aim of this study is to evaluate whether the use of a xenogenic collagen matrix (XCM) for the treatment of multiple adjacent gingival recessions (MAGRs) with a multiple coronally advanced flap technique (mCAF) achieves better results than the use of an autologous connective tissue graft (CTG) in terms of recession reduction (primary outcome) and other secondary root coverage outcomes (e.g. complete root coverage, mean root coverage). Moreover, this study aims to compare secondary clinical variables (e.g. keratinized tissue width (KTW) changes, probing pocket depth (PPD) changes, volumetric gain (VG), etc.), also with a digital approach, the patient-reported outcome measures (PROMs e.g. pain, swelling, bleeding). The hypothesis of this study is that at 6 months and 1 year follow-up the mCAF with XCM is not inferior to CTG in terms of recessions reduction and secondary clinical variables, and superior regarding to PROMs.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • At least 18 years old and able to sign informed consent
  • At least 2 adjacent teeth with RT1 and/or RT2 gingival recessions without interproximal exposure of the CEJ (interdental gingival recession), at least one with a depth of ≥2mm with indication for root coverage treatment
  • A minimum of 4 adjacent teeth (including the ones to be treated) in the region of interest
  • Available to attend study related procedures (including follow-up visits)

Exclusion criteria

  • Systemic diseases/medications which could influence the outcome of the therapy (e.g., uncontrolled diabetes mellitus);
  • Current smokers (self-reported, any type of smoking), users of chewing tobacco, and drug/alcohol abusers;
  • Pregnant or nursing women;
  • History of previous periodontal surgery (mucogingival or other) on the teeth to be included;
  • Furcation involvement in the teeth to be included;
  • Presence of severe tooth malposition, rotation or clinically significant extrusion in the teeth to be treated;
  • Presence of fixed or removable prosthesis in the area to be treated

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

Xenogenic collagen matrix (XCM)
Experimental group
Description:
Multiple coronally advanced flap technique (mCAF) with the use of a XCM
Treatment:
Device: Use of XCM for the treatment of MAGRs with mCAF technique
Connective tissue graft (CTG)
Active Comparator group
Description:
Multiple coronally advanced flap technique (mCAF) with the use of a CTG
Treatment:
Procedure: Treatment of MAGRs with CTG

Trial contacts and locations

1

Loading...

Central trial contact

Mario Aimetti, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems